Literature DB >> 9806054

Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1.

S J Bersoff-Matcha1, M M Horgan, V J Fraser, L M Mundy, B P Stoner.   

Abstract

Recent evidence suggests that sexually transmitted diseases (STDs) enhance the transmission of human immunodeficiency virus (HIV) type 1. In 143 HIV-infected women enrolled in a university-based longitudinal HIV clinic over 16 months (mean), the STD point prevalence was examined at enrollment and the cumulative prevalence was calculated at follow-up. At enrollment, 35 women (25%) had > or = 1 STD. These included trichomoniasis in 16 women (11%); syphilis, 9 (6%); genital herpes, 8 (6%); gonorrhea, 5 (4%); chlamydia, 5 (4%); genital warts, 2 (1%); and pelvic inflammatory disease (PID), 1 (1%). STDs were found in 55 (42%) of the 125 patients who returned for at least one follow-up visit: trichomoniasis in 23 (18%); genital herpes, 20 (12%); gonorrhea, 9 (7%); syphilis, 7 (6%); genital warts, 7 (6%); chlamydia, 5 (4%); and PID, 4 (3%). Despite counseling at both enrollment and follow-up, these women had a very high cumulative prevalence of STDs, indicating persistent high-risk sexual behavior.

Entities:  

Mesh:

Year:  1998        PMID: 9806054     DOI: 10.1086/515678

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  "He won't use condoms": HIV-infected women's struggles in primary relationships with serodiscordant partners.

Authors:  Patricia E Stevens; Loren Galvao
Journal:  Am J Public Health       Date:  2007-04-26       Impact factor: 9.308

3.  The association between Trichomonas infection and incarceration in HIV-seropositive and at-risk HIV-seronegative women.

Authors:  Ank E Nijhawan; Alison K DeLong; David D Celentano; Robert S Klein; Jack D Sobel; Denise J Jamieson; Susan Cu-Uvin
Journal:  Sex Transm Dis       Date:  2011-12       Impact factor: 2.830

4.  Sexually transmitted infections among HIV seropositive men and women.

Authors:  S C Kalichman; D Rompa; M Cage
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

5.  Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Megan Gatski; David H Martin; Rebecca A Clark; Emily Harville; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

Review 6.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

Review 7.  Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans.

Authors:  Shira C Shafir; Frank J Sorvillo; Lisa Smith
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

8.  The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Alys Adamski; Rebecca A Clark; Leandro Mena; Harold Henderson; Judy Levison; Norine Schmidt; Hirut T Gebrekristos; David H Martin; Patricia Kissinger
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

9.  Prevalence of sexually transmitted infections in HIV positive and HIV negative females, in a tertiary care hospital - An observational study.

Authors:  Dimple Chopra; Ivy Sandhu; R K Bahl; Ruby Bhatia; Anupama Goyal
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jan-Jun

10.  Substance use and sexually transmitted infections among anti-retroviral treatment attendees in jimma university specialized hospital, jimma, ethiopia.

Authors:  Shimelis Mitiku; Andualem Mossie; Sintayehu Fekadu
Journal:  Ethiop J Health Sci       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.